Cero Therapeutics regains Nasdaq compliance after bid price deficiency

Related
Expeditors cut to Sell equivalent at BofA as container rates...
10 minutes ago
0
Stacey Abrams has some advice for companies erasing DEI from...
37 minutes ago
0
CEL-SCI announces pricing of $5.7 million offering
40 minutes ago
0
Argus initiates CoreWeave with Buy rating due to AI infrastr...
42 minutes ago
0
Catalyst Watch: Bank earnings rush, OPEC report, Tesla EVs g...
44 minutes ago
0
U.S. drilling rigs drop for 11th straight week in Baker Hugh...
44 minutes ago
0
JPMorgan said to start charging fintechs for customer data a...
47 minutes ago
0
Trending
Popular
© FBT Company 2025. All rights are reserved